YA II PN, Ltd. 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 7:39 pm Sale | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 0 0.000% | -9,898 (Position Closed) | Filing |
| 2024-02-12 4:37 pm Purchase | 2023-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 9,898 9.990% | 2,280 (+29.93%) | Filing |
| 2023-01-03 3:58 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 7,618 9.990% | 3,603 (+89.75%) | Filing |
| 2022-01-11 4:52 pm Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 4,015 9.990% | 666 (+19.89%) | Filing |
| 2021-10-07 6:24 pm Purchase | 2021-10-07 | 13G | NLS Pharmaceutics AG NLSP | YA II PN, Ltd. | 3,349 9.990% | 3,349 (New Position) | Filing |